Wednesday, September 26, 2012

OTC Tech Stock Trading Alert; Mimvi (OTC: MIMV) Continues Run on Microsoft (MFST) News


New York, NY - September 26, 2012 (Investorideas.com newswire, www.techsectorstocks.com) Investorideas.com staff: Investor Ideas, www.InvestorIdeas.com, a global investor research portal for independent investors, issues a tech stock trading alert for Mimvi, Inc. (OTC: MIMV), currently trading at $0.62, up 0.05 or 8.77% as of 10:02AM EDT on over 2.3 Million shares. The stock had a morning high of $0.72.
The stock soared following news yesterday when it announced that it has finalized a partnership agreement with Microsoft Corp (NASDAQ:MFST). The partnership will see Mimvi develop a number of products and services to complement Microsoft's Windows Azure and Windows Mobile 8 Platforms. The agreement also involves Microsoft making investments in Mimvi in the form of engineering services, software, and cash.
Investorideas.com Newswire About Investorideas.com
InvestorIdeas.com is a leader in investor stock research with a focus on energy and water. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook
http://www.facebook.com/Investorideas
Get free investor news and stock alerts for tech stocks and other sectors
Sign Up: http://www.investorideas.com/ Resources/ Newsletter.asp
Join Investor Ideas Get 14 of the best stock directories online;
Research tech stocks, oil and gas stocks, gold stocks, water stocks, renewable energy stocks and more
Join: http://www.investorideas.com/ membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . Disclosure: MIMV is a previous expired showcase tech stock on Investorideas.com www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Tuesday, September 25, 2012

Biodefense Stock Trading Alert: PositiveID (OTCBB: PSID) Gains 40% on News

New York, NY - September 25, 2012 (Investorideas.com Newswire, www.biodefensestocks.com) Investorideas.com, a leader in research for independent investors issues a trading alert for biodefense stock, PositiveID Corporation (OTCBB: PSID) trading up over 40% following news today.
The Company reported an update to its stockholders on its pursuit of BioWatch Generation 3, Phase II. Two weeks ago, the Department of Homeland Security ("DHS") revised its procurement strategy for BioWatch Generation 3, Phase II, which now will consist of a two-stage procurement which includes two to three years of testing estimated at $89 million. A draft request for proposal ("RFP") on this effort is scheduled for release in the fourth quarter of calendar 2012. PositiveID's patented M-BAND biodetector was developed under a competitive award from the DHS Science & Technology Directorate ("S&T").
Investorideas.com Newswire About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.www.PositiveIDCorp.com.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/ today/ investorideas.com
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com:
Contact: 800 665 0411

Biotech Stock News; Aethlon Medical (OTCBB: AEMD) To Present at the Exosomes and Microvesicles 2012 Conference

SAN DIEGO - September 25, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), disclosed today that its Chairman and CEO, Jim Joyce will present at the Exosomes and Microvesicles 2012 conference, which is being hosted by The American Society for Exosomes and Microvesicles. The event will be held at the Wyndham Lake Buena Vista Resort in Orlando, Florida and runs from September 29th through October 2nd. Mr. Joyce's presentation is scheduled for 10:10 a.m. on October 2nd and is entitled: Extracorporeal clearance of tumor-secreted exosomes as an adjunct to enhance cancer therapy efficacy. Additional information on the event can be found online at www.exosomesandmicrovesicles.org.
Investorideas.com Newswire
The Aethlon Medical presentation will review the attributes of the Aethlon Hemopurifier® as an adjunct medical device that can be combined with chemo and immunotherapies as a strategy to improve cancer treatment outcomes. The Hemopurifier®, which is a first-in-class device being advanced in Hepatitis C (HCV) care, has also demonstrated the ability to capture cancer-promoting exosomes secreted by tumors. Tumor-secreted exosomes have emerged to become a potentially vital therapeutic target in cancer as researchers have reported these microvesicular particles promote tumor progression by inducing programmed cell death of anti-cancer immune cells. As a result of inhibiting the immune response, exosomes increase the proliferation and spread of many forms of cancer. Researchers have also reported that exosomes seed the spread of metastasis, promote angiogenesis (essential for tumor survival and growth), increase tumor aggressiveness, and contribute to anti-cancer drug resistance.

About Aethlon Medical
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT™ system including the ability to introduce a targeted breast cancer therapy known as HER2osome™, there is no assurance that FDA will approve the initiation of the company's clinical programs or provide market clearance of the company's products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page on Investorideas.comDisclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) Investorideas.com is paid by AEMD to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs

Homebuilder Stock Trading Alert: Home Depot (NYSE:HD) Breaks 52-Week High

New York, New York - September 25, 2012 (www.investorideas.com newswire. www.homebuilderstocknews.com) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including homebuilder stocks issues a trading alert for The Home Depot, Inc. (NYSE :HD), currently trading at $60.15, up 0.76 or 1.29% as of 10:30AM on 1.8 Million shares. The stock broke through its 52 week high of $60.00 in this morning's trading session.
The homebuilding sector has had several stocks break through 52 week highs recently with stronger housing data coming in.
Investorideas.com Newswire The Home Depot is the world's largest home improvement specialty retailer, with 2,250 retail stores in all 50 states, the District of Columbia, Puerto Rico, U.S. Virgin Islands, Guam, 10 Canadian provinces and Mexico. In fiscal 2011, The Home Depot had sales of $70.4 billion and earnings of $3.9 billion. The Company employs more than 300,000 associates. The Home Depot's stock is traded on the New York Stock Exchange (HD) and is included in the Dow Jones industrial average and Standard & Poor's 500 index.
About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including homebuilder stocks, beverage stocks, water stocks, biotech stocks and more.
Research homebuilder stocks at the Investorideas.com stock directory:
http://www.investorideas.com/Companies/HomebuilderStocks/HomebuilderStockList.asp
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 14 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Biotech Stock News: Sunshine Biopharma's (OTCBB: SBFM) Adva-27a Preclinical Research Results to Be Published in October Issue of ANTICANCER RESEARCH

MONTREAL - September 25, 2012 (Investorideas.com Newswire) Sunshine Biopharma Inc. (OTCBB:SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, reports that its paper on Adva-27a preclinical research results has been accepted and will be published in the October issue of ANTICANCER RESEARCH, a peer-reviewed International Journal of Cancer Research and Treatment.

Adva-27a is Sunshine Biopharma's lead anti-cancer compound which has been shown to be effective at killing multidrug resistant cancer cells in vitro. Multidrug resistant cancer cells do not respond to any of the chemotherapy drugs currently in use for cancer treatment. The manuscript, which was prepared by Sunshine Biopharma scientists in collaboration with scientists from Binghamton University in New York and from Ecole Polytechnique in Montreal (Canada), contains a substantial amount of data compiled from experiments conducted by these scientists.
ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology (http://ar.iiarjournals.org).
Articles in ANTICANCER RESEARCH are regularly indexed in all bibliographic services, including Current Contents (Life Sciences), Science Citation Index, Index Medicus, Biological Abstracts, PubMed, Chemical Abstracts, Excerpta Medica, University of Sheffield Biomedical Information Service, Current Clinical Cancer, AIDS Abstracts, Elsevier Bibliographic Database, EMBASE, Compendex, GEOBASE, EMBiology, Elsevier BIOBASE, FLUIDEX, World Textiles, Scopus, Progress in Palliative Care, Cambridge Scientific Abstracts, Cancergram (International Cancer Research Data Bank), MEDLINE, Reference Update - RIS Inc., PASCAL-CNRS, Inpharma-Reactions (Datastar, BRS), CABS, Immunology Abstracts, Telegen Abstracts, Genetics Abstracts, Nutrition Research Newsletter, Dairy Science Abstracts, Current Titles in Dentistry, Inpharma Weekly, BioBase, MedBase, CAB Abstracts/Global Health Databases, Investigational Drugs Database, VINITI Abstracts Journal, Leeds Medical Information, PubsHub, Sociedad Iberoamericana de InformaciĆ³n Cientifica (SIIC) Databases.
About Sunshine Biopharma Inc. (OTCBB : SBFM ):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer (www.sunshinebiopharma.com).
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
Contact:
For Additional Information
Camille Sebaaly
CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Published at Investorideas.com newswire
Learn more about Sunshine Biopharma Inc. (OTCBB:SBFM): Profile
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensates Investorideas.com for news release publishing and distribution : one hundred thousand 144 shares for three months starting June 26th
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Monday, September 24, 2012

Biodefense Stock Breaking News: PositiveID Corporation (OTCBB: PSID) Comments on Department of Homeland Security's Revised Procurement Strategy for BioWatch Generation 3, Phase II

DELRAY BEACH, Fla. - September 24, 2012 - (Investorideas.com Newswire) PositiveID Corporation (OTCBB: PSID) ("PositiveID" or "Company"), an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for diabetes management and rapid medical testing, today provided an update to its stockholders on its pursuit of BioWatch Generation 3, Phase II. Two weeks ago, the Department of Homeland Security ("DHS") revised its procurement strategy for BioWatch Generation 3, Phase II, which now will consist of a two-stage procurement which includes two to three years of testing estimated at $89 million. A draft request for proposal ("RFP") on this effort is scheduled for release in the fourth quarter of calendar 2012. PositiveID's patented M-BAND biodetector was developed under a competitive award from the DHS Science & Technology Directorate ("S&T").

The purpose of BioWatch Generation 3, Phase II is to obtain a fully autonomous networked biodetection capability that will be deployed, operated, and sustained, both indoor and outdoor, in selected U.S. BioWatch jurisdictions to continuously monitor the air for agents of biological concern. The original procurement outlined in the draft solicitation released by DHS in August 2011, with an estimated contract value of $3.1 billion, contemplated a single procurement resulting in a single award Indefinite Delivery Indefinite Quantity (IDIQ) contract for Performance Testing, Low Rate Initial Production (LRIP), Operational Test & Evaluation (OT&E), Detector Production, Deployment, Sustainment and Disposal.
The revised strategy, released by DHS two weeks ago, would consist of a two-stage procurement using a competitive down-selection between stages. Stage 1 would be for Performance Testing of candidate systems and may result in the award of multiple contracts depending on the technical merits of proposals submitted and the availability of funding. Stage 2 would be a separate competition and result in the award of a single contract for LRIP, OT&E, Full Rate Production, Deployment, Sustainment and Disposal. To be considered for the Stage 2 award, a company would need to demonstrate a design maturity and data set equivalent to that of Stage 1 participants.
William J. Caragol, Chairman and CEO of PositiveID, stated, "We believe the revised strategy for BioWatch, allowing for performance testing of qualifying systems in preparation for the full roll-out of the $3.1 billion procurement, provides us an opportunity to prove our M-BAND system, the only system of its kind that was demonstrated previously in the field under the DHS S&T BAND Program. Additionally, we continue to have discussions with potential strategic partners to prepare the Company for success in BioWatch Gen-3, Phase II."
About PositiveID Corporation OTCBB:PSID)
PositiveID Corporation is an emerging growth developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense industry. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that it has made significant progress realigning its business with a focus on its molecular diagnostics platform; the likelihood that the Company also continues to make strong progress in the diabetes management segment of its business; the likelihood that the Company will enter into strategic partnerships and/or teaming agreements with large government contractors for M-BAND manufacturing and system integration for BioWatch Gen-3; the likelihood that the Company will submit a proposal upon release of the final BioWatch Gen 3 RFP, currently scheduled for release in the fourth quarter of calendar 2012, from Department of Homeland Security for the $3.1 billion BioWatch Gen-3 procurement; the likelihood that the Company will commence the second stage of Easy Check clinical study at Schneider Children's Medical Center in Israel; the likelihood that the Company will complete a bench-top unit of the GlucoChip glucose-sensor and initiate strategic partnerships; the likelihood that the Company will continue development of its Dragonfly Rapid MDx Cartridge-based diagnostic system for point-of-care diagnostics; the likelihood that the Company will complete the license and/or sale of the VeriChip and iglucose product lines to position them with the best partners for market exploitation and monetization; the likelihood that the Company will complete a strategic financing to capitalize the Company to execute on these opportunities; the likelihood that significant opportunities that lie ahead, including BioWatch Gen 3 and the continued development of the Company's innovative Dragonfly system; the likelihood that the Company will continue to execute its plan, described above; the likelihood that the Company is well positioned to capitalize on the BioWatch Gen 3 opportunity and to make meaningful steps in the commercialization of our diabetes management products; the likelihood that that progress, in conjunction with a strategic financing to fully capitalize the Company, will allow the Company to unlock value for stockholders; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully commercialize its M-BAND system and Dragonfly system, as well as its diabetes management products; the Company's ability to complete the license and/or sale of the VeriChip and iglucose product lines to position them with the best partners for market exploitation and monetization; the Company's ability to attract strategic partners; the Company's ability to complete a strategic financing; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 28, 2012, and 10-Qs filed on August 20, 2012, May 14, 2012, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

OTCBB Mid-Day Movers; ATTD, MFTH, FRCN, APDN

New York, New York - September 24, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors reports on the top ten volume traders on the OTCBB for mid day trading
Attitude Drinks Inc (OTCBB: ATTD) is last at $0005, down -0.0003 or 37.50% on volume of 48.56 Million shares.
Medisafe 1 Technologies Corp. (OTCBB: MFTH) is trading at $ 0.0058, up 0.0001 or 1.75% on 21.48 Million.
Firemans Contractors Inc. (OTCBB: FRCN) is last at $0.0034, up 0.0016 or 88.89% on 18.87 Million shares changing hands.
Investorideas.com Newswire Applied DNA Sciences Inc. (OTCBB: APDN) is trading up at $ 0.264. Gaining 0.0445 or 20.27% on volume of 10.48 Million.
Amarantus Biosciences Inc. (OTCBB: AMBS) is trading at $ 0.01, up 0.0049 or 96.08% on 5 7.61 Million

Advanced Cell Technology Inc. (OTCBB: ACTC) is down, trading at $0.0773, the negative -0.0027 or 3.38% on 5.18 Million shares.
Active Health Foods Inc. (OTCBB: AHFD) is trading at $ 0.0028, down -0.0002 or 6.67% on 3.37 Million shares.
Digerati Technologies Inc. (OTCBB: DTGI) is trading at $ 0.004, down -0.0002 or 4.76 on volume of 3.08 Million.
AccelPath Inc. (OTCBB: ACLP) is trading up at $ 0.017, gaining 0.01 or 142.86% on 2.87 Million shares.
Internal Fixation Systems Inc. (OTCBB: IFIX) is trading at $0.0024, up 0.0002 or 9.09%on 2.55 Million shares.
About OTCBB:
http://www.otcbb.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 13 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Homebuilder Stocks Breaking News: Lennar (NYSE:LEN) Reports Third Quarter EPS of $0.40

New York, New York - September 24, 2012 (Investorideas.com newswire, www.homebuilderstocks.com) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including homebuilder stocks issues an investor alert for Lennar Corporation (NYSE:LEN and LEN.B), reporting third quarter earnings . The stock traded as high as $38.27 following the earnings news but has pulled back with the general markets. The stock is now trading at $36.71, down 0.80(2.13%) 10:41AM EDT on over 5.7 Million shares volume.

Earnings Summary -
  • Net earnings of $87.1 million, or $0.40 per diluted share, compared to net earnings of $20.7 million, or $0.11 per diluted share
  • Deliveries of 3,655 homes - up 28%
  • New orders of 4,198 homes - up 44%; cancellation rate of 17%
  • Backlog of 4,513 homes - up 79%; backlog dollar value of $1.3 billion - up 95%
  • Revenues of $1.1 billion - up 34%
  • Gross margin on home sales of 23.2% - improved 210 basis points
  • S, G&A expenses as a % of revenues from home sales of 12.0% - improved 230 basis points
  • Operating margin on home sales of 11.2% - improved 440 basis points
  • Lennar Homebuilding operating earnings of $71.3 million, compared to $27.1 million
  • Lennar Financial Services operating earnings of $25.3 million, compared to $8.0 million
  • Rialto Investments operating earnings totaled $7.7 million (including $13.4 million of net loss attributable to noncontrolling interests), compared to $5.7 million (net of $6.1 million of net earnings attributable to noncontrolling interests)
  • Lennar Homebuilding cash and cash equivalents of $692.0 million
  • Issued $400 million of 4.75% senior notes due 2017
  • Completed the repurchase of $204.7 million aggregate principal amount of 5.95% senior notes due 2013 through a tender offer, resulting in a $6.5 million pre-tax loss
  • No outstanding borrowings under the $525 million credit facility
  • Lennar Homebuilding debt to total capital, net of cash and cash equivalents, of 47.7%
Investorideas.com Newswire Lennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. The Company builds affordable, move-up and retirement homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title insurance and closing services for both buyers of the Company's homes and others. Lennar's Rialto Investments segment is focused on distressed real estate asset investments, asset management and workout strategies. Previous press releases and further information about the Company may be obtained at the "Investor Relations" section of the Company's website, www.lennar.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including homebuilder stocks, beverage stocks, water stocks, biotech stocks and more.
Research homebuilder stocks at the Investorideas.com stock directory:
http://www.investorideas.com/Companies/ HomebuilderStocks/ HomebuilderStockList.asp
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/ investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/ Resources/Newsletter.asp
Become an Investorideas.com Member and access 14 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Friday, September 21, 2012

TSX Top Trader: Gold Stock CGA Mining (TSX:CGA) (ASX:CGX)

New York, New York - September 21, 2012 (Investorideas.com Mining stocks newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors reports on the top volume trader for Friday’s session. CGA Mining Limited (TSX:CGA.TO) (ASX:CGX) leads , trading at $2.99, gaining 0.20 or 7.17% as of 1:31PM EDT on over 14.6 Million shares. The stock had a high of $3.03.
Investorideas.com Newswire CGA is listed on the main board of the Toronto Stock Exchange and ASX. The Masbate Gold Project in the Philippines was successfully constructed with first gold poured mid-2009. The project has a total measured and indicated resource base of 5.13M ounces of gold, total inferred resource base of 2.83M ounces of gold and a proven and probable reserve of 3.097M ounces of gold.
About TSX

http://www.tmx.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts including TSX alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Renewable Energy Stock Breaking News: Syntroleum (Nasdaq:SYNM) Moves on Patent News

New York, NY - September 21, 2012 (Investorideas.com renewable energy newswire) Investorideas.com staff - Investorideas.com, a leader in renewable energy stock research for independent investors, issues a trading alert for Syntroleum Corp. (NasdaqCM:SYNM), trading at $0.85, gaining 0.08 or 10.39% as of 11:29AM EDT on over 255,000 shares.
Investorideas.com Newswire The Company announced today that on September 14, 2012, the U.S. Patent & Trademark Office ("PTO") issued an Order granting Syntroleum Corporation's (SYNM) August 17th request for inter partes reexamination of U.S. Patent No. 8,187,344 and also issued an Office Action rejecting all claims of the patent as obvious in view of the prior art. The '344 patent is the subject of a patent suit filed by Neste Oil Oyj against Syntroleum on May 29, 2012 in the District of Delaware. The '344 patent is related to and shares the same inventors as a prior Neste patent (U.S. Patent No. 7,279,018), and both are directed to a fuel composition for diesel engines. The PTO's recent Order is consistent with a prior finding on March 22, 2012 by the PTO's Board of Patent Appeals and Interferences affirming the Examiner's rejection of the '018 patent's claims because "the evidence of record as a whole supports the Examiner's conclusion that the fuel composition as claimed would have been obvious to one of ordinary skill in the art ...". Neste declined to appeal this ruling and on July 31, 2012, the PTO issued a Reexamination Certificate canceling all claims of the '018 patent.
Syntroleum's Answer to Neste's First Amended Complaint regarding the '344 patent is due on September 24th, and Syntroleum's Motion to Stay the district court action in view of the PTO reexamination proceedings is pending. Syntroleum has not infringed any of Neste's alleged patent rights and Syntroleum will continue to vigorously defend against the complaint's allegations. Syntroleum will also pursue invalidity of the '344 patent via the PTO reexamination proceedings, and is confident that its position will be vindicated.

About Syntroleum (SYNM)
Syntroleum Corporation owns the Syntroleum(R) Process for Fischer-Tropsch (FT) conversion of synthesis gas into liquid hydrocarbons, the Synfining(R) Process for upgrading FT liquid hydrocarbons into refined petroleum products, and the Bio-Synfining(R) technology for converting renewable feedstocks into drop-in fuels. Syntroleum has a 50% interest in Dynamic Fuels, LLC, which operates a 75 million gallon per year renewable fuels facility located in Geismar, Louisiana utilizing its Bio-Synfining(R) technology. For additional information, visit the Company's web site at www.syntroleum.com
Research more solar stocks on global stock exchanges -and up to 1400 renewable energy stocks at Investorideas.com http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411

Healthcare Stock Breaking News: GreeneStone (OTCBB:GRST) Addresses Eating Disorder Epidemic with Expanded Clinical Staff and Clinic Launch in Autumn 2012

September 21, 2012 (Investorideas.com newswire) GreeneStone Healthcare Corporation (OTCBB:GRST), provider of Mental Healthcare and Corporate Healthcare Services, today announced the hiring of Ann Kerr as Clinical Director at its new Eating Disorder clinic. In addition to Ms. Kerr, the Company has chosen a psychiatrist medical director, head psychologist, and Chief Clinical Advisor, all of whom will formally be announced once they are under contract. In addition the recently announced new hire, Dr. Mohsina Chaklader, at the company’s ‘ Center of Excellence for Gastroenterology’ will be a valuable resource for the Eating Disorder clinic.

In the United States, as many as 10 million females and 1 million males are suffering from an eating disorder such as anorexia and bulimia and millions more are struggling with binge eating disorders. While awareness of eating disorders is improving, the public, health care providers and educators frequently have little understanding of eating disorders, how to recognize symptoms and how to communicate with people dealing with eating disorders. Eating disorders are very difficult to treat and can require lifelong treatment. The goal of the Company will be to stay with and support patients throughout their time of need, while striving to achieve sufficient improvement so that in-patient care is reduced and outpatient and ongoing care can begin.
Corporate Healthcare and disability costs are growing steadily higher and effective treatment for those suffering from mental health and mental health related issues will be the solution to reducing those costs. The Company has an increasing number of specialists in the treatment of mental health related disorders. “These are by far the largest component of corporate healthcare costs,” stated Mr. Shawn Leon, CEO. He added, “We see this as the biggest area of growth for the Company and we need to be national in scope.”
Ann Kerr is a Registered Occupational Therapist and holds academic appointments as Assistant Professor in the Department of Psychiatry, and Lecturer in the Department of Occupational Therapy in the Faculty of Medicine at The University of Toronto. She has worked in the field of mental health for over 30 years and specialized in the care for people affected by eating disorders through work in Inpatient, Day Hospital, community, and private practice settings. Ann was part of the team that built the Inpatient Eating Disorder Program at Toronto General Hospital under Dr. Sid Kennedy, and then the first ever Eating Disorder Day Hospital Program with Drs Allan Kaplan and Niva Piran. Ann accepted the position of the first Program Director of Sheena’s Place, an innovative model of support services for families and people with eating disorders. Ann has been in private practice in Toronto for the past six years honing her psychotherapy skills in the areas of CBT, DBT and Relational Therapy.
Ann was trained at The University of Toronto and has ongoing education through Harvard Medical School of Continuing Education and the Jean Baker Miller Centre at Wellesley College. She has supervised students in most health professions and been awarded the Northrop Frye teaching award for medical student education. Ann was on the Board of the Transitional College of Occupational Therapists and is a Member of the College of Occupational Therapists of Ontario and the Ontario Association of Occupational Therapists. She is a member of the Academy of Eating Disorders, an international body of eating disorder clinicians and researchers. Ann has written research articles and chapters in books on the treatment of people with eating disorders as well as having spoken at numerous conferences in Canada and the USA. She has appeared frequently on television, radio and in newspapers and magazines commenting on current issues in the culture that relate to this issue.
Limited operations at the Eating Disorder clinic are set to begin in late October, with full service operations intended to commence in early 2013. The primary mission of the clinic will be to treat anorexia and bulimia through a combination of services, including in-patient care, intensive outpatient care, ongoing support, after-care and counseling. The company plans to offer the very best in care and hopes to earn a reputation for the best care available in the country.
About GreeneStone Healthcare Corporation
GreeneStone Healthcare Corp. (GRST) is a provider of mental health services, specializing in the areas of addiction treatment, eating disorders, nutrition and weight loss, and executive healthcare. GreeneStone is among the many nascent healthcare companies re-defining the healthcare space for the modern economy, which include Roche Holding Ltd. (RHHBY), Sarepta Therapeutics Inc. (SRPT), Nektar Therapeutics (NKTR), Celldex Therapeutics, Inc. (CLDX), Achillion Pharmaceuticals, Inc. (ACHN), Zogenix, Inc. (ZGNX). The company operates medical and healthcare clinics in Ontario, Canada, serving a North American and international clientele. GreeneStone’s clinics meet several ends: (1) GreeneStone adds overflow capacity to an increasingly stretched public healthcare system in Canada, (2) GreeneStone mental health clinics provide private alternatives to publicly available but highly underserviced healthcare subsectors, and (3) GreeneStone meets newly developing healthcare needs undisturbed by the public/private market, such as eating disorders. The company is headquartered in Toronto, Canada.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). To the extent that any statements made in this press release contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as “expect,” “plan,” “will,” “may,” “anticipate,” “believe,” “should,” “intend,” “estimate,” and variations of such words. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, those risks and uncertainties contained in this press release and those identified in the periodic reports that the company files with the Securities and Exchange Commission (the “SEC”) pursuant to the Exchange Act.
Investor information and email sign-up:
http://www.greenestoneinvestor.com
Contact:.
GreeneStone Healthcare Corporation
Shawn Leon, 416-222-5501
investor@greenestoneinvestor.com
www.greenestoneinvestor.com
Published at the Investorideas.com Newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com was compensated five hundred for the publication and distribution of this news release .
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Thursday, September 20, 2012

TSX Energy Stock on the Move: Canacol Energy (TSX:CNE) Gains over 14% on News of Increased Proven Reserves

New York, New York - September 20, 2012 (Investorideas.com Energy Stocks Newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors issues a trading alert for Canacol Energy (TSX:CNE.TO), trading at $0.51, gaining 0.0650 or 14.61% as of 10:54AM EDT on over 5.5 Million shares, making it one of the top traders on the TSX in morning trading . The stock traded as high as $.54 on news of an increased of 98% in proven reserves.

The Company reported "Total corporate proved reserves ("1P") plus deemed volumes ("DV") for the fiscal year ended June 30, 2012 increased 98% to 10.5 million barrels ("MMbbls") from 5.3 MMbbls for the fiscal year ended June 30, 2011, with a corresponding 1P reserve replacement of 121%(i). In the same period, 1P plus DV pre-tax NPV-10 increased 55% from US $199.2 million to US $308.4 million. Total corporate proved plus probable reserves ("2P") plus DV increased to 16.1 MMbbls for the fiscal year ended June 30, 2012. In the same period, 2P plus DV pre-tax NPV-10 increased to US $492.1 million. The Corporation's 2P plus DV represents 94% oil and 6% gas liquids.”
Canacol Energy is an exploration and production company with operations focused in Colombia and Ecuador.
Investorideas.com Newswire About TSX
http://www.tmx.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts including TSX alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Homebuilder Stocks Snapshot: BZH, KBH, PHM, TOL

New York, New York - September 20, 2012 (Investorideas.com newswire, www.homebuilderstocks.com) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including homebuilder stocks issues a sector snapshot for the sector.

Yesterday NAHB (http://www.nahb.org) reported that Nationwide housing production rose 2.3 percent to a seasonally adjusted annual rate of 750,000 units in August, according to newly released figures from HUD and the U.S. Census Bureau. This increase was fueled entirely by gains in the single-family sector, where the pace of new construction rose in every region for a combined 5.5 percent gain to 535,000 units.
"Builders across the country have been reporting noticeable improvement in the number of serious buyers who are in the market for a new home, and today's report shows that this is translating to some welcome gains in construction activity," said Barry Rutenberg, chairman of the National Association of Home Builders (NAHB) and a home builder from Gainesville, Fla. "While there is still plenty of room for improvement, it's encouraging to see this continuing trend that is spurring much-needed job growth." For every 100 new single-family homes that are built, 300 new jobs are created, he noted.
Beazer Homes USA Inc. (NYSE:BZH) is trading at $3.80, up 0.05 or 1.33% as of 10:48AM EDT on over 1.8 Million shares.
KB Home (NYSE:KBH) is trading at $13.10, currently down 0.06 or 0.42% as of 10:52AM EDT on over 2.2 Million shares. The stock traded as high as $13.20 in earlier trading.
PulteGroup, Inc. (NYSE:PHM) is trading at $16.44, down 0.01 or 0.06% as of 10:54AM EDT on over 6 Million shares. The stock was up in earlier trading with a high of $16.55.
Toll Brothers Inc. (NYSE:TOL) is trading down slightly at $ 36.40, down 0.01 or 0.04% as of 10:55AM EDT, with a morning high of $36.63.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including homebuilder stocks, beverage stocks, water stocks, biotech stocks and more.
Research homebuilder stocks at the Investorideas.com stock directory:
http://www.investorideas.com/Companies/HomebuilderStocks/HomebuilderStockList.asp
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 14 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Wednesday, September 19, 2012

Energy Stock Trading Alert: FieldPoint Petroleum (NYSE:FPP) Reaches Day high of $5.21 on Well Update and 2012 Guidance

New York, New York - September 19, 2012 (Investorideas.com Energy Stocks Newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors issues a trading alert for oil and gas stock, FieldPoint Petroleum Corporation ( NYSE/MKT:FPP), trading as high as $5.21 on three times its regular volume on well news and 2012 guidance.

The Company provided an update on the latest production information from its recently completed East Lusk Federal 15 well #2 in Lea County, New Mexico.
FieldPoint's President and CEO, Ray Reaves stated, "The last data we provided on this well was through September 12. From September 13 through September 17, well production in BOPD was 705, 914, 664, 795, and 827 respectively, and we continue to sell between 360 to 500 mcf per day. We will, of course, continue to watch this well with continued interest but we hope that soon we can turn our attention more to the drilling of well #3 on this property and our other exploration and acquisition activities.”
Mr. Reaves added, "If production and the price of oil holds, we believe we will see a smart increase in total revenue year over year. Accordingly, I am projecting that our 2012 revenues could be between $9.5 and $10.8 million compared to $7.2 million for 2011.”
As a reminder, FieldPoint owns a 43.75% working interest in well #2, and will own the same percentage of well #3 in section 15 of this field.
Investorideas.com Newswire About FieldPoint Petroleum Corporation
FieldPoint Petroleum Corporation is engaged in oil and gas exploration, production and acquisition, primarily in New Mexico, Oklahoma, Texas and Wyoming. For more information, please visit www.fppcorp.com .
Properties: http://www.fppcorp.com/properties.html
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - including social media and cloud computing, beverage, water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

CGA Mining (TSX: CGA) (CGX.AX) Makes Wednesday's TSX Top Traders List on News of Merger with B2Gold Corp. (TSX: BTO) (BGLPF) (BGLPF)

New York, New York - September 19, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors issues a trading alert for CGA Mining (TSX: CGA) (CGX.AX) following merger news. The stock is trading at $2.92, gaining $0.27 or 10.19% as of 11:06AM EDT on over 18 Million shares, making it one of the top traders on the TSX.
B2Gold Corp. (BTO.TO) (BGLPF) (BGLPF) (NAMIBIAN:B2G) and CGA Mining Limited (CGA.TO)(CGX.AX) announced that they have entered into a definitive Merger Implementation Agreement ("Merger Agreement") to combine the two companies at the agreed exchange ratio of 0.74 B2Gold common shares for each CGA share held, which represents a purchase price of approximately C$3.18 per CGA share and a premium of 22% using the 20 day volume weighted average share price of each respective company, and a 26% premium over the CGA closing share price on September 17, 2012 based on the closing price for the B2Gold shares as of such date. The transaction is valued at approximately C$1.1 billion.
Investorideas.com Newswire About TSX
http://www.tmx.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/ today/ investorideas.com
Sign up for the free TSX investor news and stock alerts
http://www.investorideas.com/ Resources/ Newsletter.asp
Become an Investorideas.com Member and access our 13 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Tech Stock News; WRAPmail (OTC: WRAP) is gaining ground worldwide with 3 new distributors this week in Dubai, Pakistan and Nigeria.

FORT LAUDERDALE, Fla. - September 19, 2012 (Investorideas.com newswire) WRAPmail, Inc. (OTC:WRAP) reports that the International expansion has had a flying start with 3 new Distributors in the first week of the program. "WRAPmail International Distributors become our Marketing arm in their respective territories and help us grow without associated costs until they deliver revenue" states Rolv E. Heggenhougen, Chairman & CEO. "Our goal is to get to the tipping point where our solution starts feeding on itself and all users beget new users as they see our product in the inbox" continues Heggenhougen.

RAPmail has signed over 6,100 clients worldwide. Clients come from all countries and industries as they all have two things in common: They have websites and they send emails. WRAPmail is now further focusing on Distributors that will market WRAPmail solutions around the world.
To try WRAPmail for FREE just go to: https://pro.wrapmail.com/ signup/agreement.asp
About WRAPmail:
The basic idea behind WRAPmail is to utilize the facts that almost everyone have websites, social network site(s) and also send emails every day. These emails can become complete marketing tools and help promote, brand, sell and cross-sell in addition to drive traffic to the website and conduct research. WRAPmail is available for free (with 3rd party ads) or for a small license fee at www.wrapmail.com. No routines change as users simply download a toolbar or routes emails via Google or WRAPmail's servers.
WRAPmail also helps search for missing children with every email sent by free users incorporating an RSS feed from the Center for Missing and Exploited Children  see http://www.huffingtonpost.com/ rolv-e-heggenhougen/ finding-missing-children_b_ 1540866.html
WRAPmail Solutions:
  • WRAPmail PRO: Free solution with 3rd party ads.
  • WRAPmail PRO+: Shared solution, $50/user/year, no 3rd party ads.
  • WRAPmail Enterprise
WRAPmaker and Premade WRAPS:
More than 200 premade templates are currently available for major Network Marketing/Affiliate Marketing/MLM companies, Real Estate Agents, Business, Scenery, Sports, Holidays and Animals with Social Network Interface and personalization (image, text and links).
Clients can also make 100% custom WRAPS in the WRAPmail dashboard using the WRAPmaker.
Advertising Network:
WRAPmail has its own advertising network where users can advertise in other user's emails. The concept is a mix between similar models from Facebook and Google but the difference is our focus is email and not websites. An advertiser can have a free account and there's no usage requirement to become an advertiser. Advertisers simply create their ad in the WRAPmail Dashboard; pick City, State, Country and/or Industry of other users for placement of ads. WRAPmail also has a partnership with Market Leverage for utilization of their advertising inventory.
Affiliate Programs � "Make money with every email you send anyway"
The affiliate program does not only pay for new clients signing up but is also designed to share the revenue from 3rd party ads displayed in the free users emails.
Google:
WRAPmail is a Google Apps Vendor and also compatible with Google Analytics and Google Chrome/Gmail.
Forward looking statements and risks and uncertainties
Matters discussed in this press release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. For more complete information regarding our business and financial condition, you may access our filings at otcmarkets.com. The matters discussed in this press release should not be construed in any matter, shape or form as indicative of the future value of the Company's common stock or its future financial condition.
WRAPmail Investor Relations:
IR@WRAPmail.com
Phone: (954) 591-8742
Disclaimer for Investorideas.com newswire and related syndication sites:
The following news is paid for as disclosed further in this email and /or published as free news content for information only for our readers.Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information tools to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure specifics: Investorideas and related sites have been compensated by WRAP: three thousand five hundred for one week of news and content publication and distribution.
All original content is created from public documents, SEC filings or related regulatory bodies for the exchange, Yahoo Finance, and or the company's website or management. ALL INVESTMENT INVOLVES RISK AND POSSIBLE LOSS OF ALL INVESTMENT. Please read our social media and related disclaimers at our disclaimer page .Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. If you have any questions regarding information in this press release please contact the company listed in the press release

Oil and Gas Stock Investor News Alert; FieldPoint Petroleum (NYSE/MKT:FPP) Reports Most Recent Production of Well #2 in Lea County, New Mexico at 827 BOPD

Austin, TX - September 19, 2012 (Investorideas.com Energy Stocks Newswire) FieldPoint Petroleum Corporation (NYSE/MKT:FPP ) today provided an update on the latest production information from its recently completed East Lusk Federal 15 well #2 in Lea County, New Mexico.

FieldPoint's President and CEO, Ray Reaves stated, "The last data we provided on this well was through September 12. From September 13 through September 17, well production in BOPD was 705, 914, 664, 795, and 827 respectively, and we continue to sell between 360 to 500 mcf per day. We will, of course, continue to watch this well with continued interest but we hope that soon we can turn our attention more to the drilling of well #3 on this property and our other exploration and acquisition activities."
Mr. Reaves added, "If production and the price of oil holds, we believe we will see a smart increase in total revenue year over year. Accordingly, I am projecting that our 2012 revenues could be between $9.5 and $10.8 million compared to $7.2 million for 2011."
As a reminder, FieldPoint owns a 43.75% working interest in well #2, and will own the same percentage of well #3 in section 15 of this field.
About FieldPoint Petroleum Corporation
FieldPoint Petroleum Corporation is engaged in oil and gas exploration, production and acquisition, primarily in New Mexico, Oklahoma, Texas and Wyoming. For more information, please visit www.fppcorp.com .
Properties: http://www.fppcorp.com/properties.html
Investorideas.com Newswire This press release may contain projections and other forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such projections or statement reflect the company's current views with respect to future events and financial performance. No assurances can be given, however, that these events will occur or that such projections will be achieved and that actual results could differ materially from those projected. A discussion of important factors that could cause actual results to differ from those projected, such as decreases in oil and gas prices and unexpected decreases in oil and gas production is included in the company's periodic reports filed with the Securities and Exchange Commission (at www.sec.gov).
Contact: Ray D. Reaves, President (512)250-8692 or fppc@ix.netcom.com
Published at Investorideas.com energy stocks newswire
Sign up for the free energy stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Investorideas.com was compensated one thousand for news publishing and distribution. More http://www.investorideas.com/About/Disclaimer.asp